Camlin Fine Sciences stock score and checklist

Camlin Fine Sciences (CAMLINFINE) ranked on quality, valuation and momentum against 1,356 NSE stocks, with an 18-point checklist. Prices as of 18 Nov 2026; results to the quarter ended Sep 2026.

· data for the trading session of Wed 18 Nov 2026

Quality
19 / 100
Weak
From 6 of 6 components
Valuation
n/a
n/a
Loss over the last four quarters: P/E-based valuation does not apply
Momentum
1 / 100
Weak
From 4 of 5 components

Weak quality · Valuation n/a · Weak momentum. Passes 5 of 15 applicable checks.

How each score is made

Every number is ranked against the same number for the other 1,355 scored stocks. The percentile is the share of them it beats (0–100); a score is the average percentile of the components the stock has.

Quality: 19 (Weak)

Profitability, balance sheet strength and steady growth.

ComponentCamlin Fine SciencesPercentile
Return on equity (ROE)Profit over the last four quarters ÷ average shareholders’ equity. Higher ranks higher.-0.8%5
Return on capital employed (ROCE)Pre-tax profit + interest ÷ equity + borrowings. Higher ranks higher.-1.6%3
Debt / equityBorrowings ÷ equity (lease liabilities are not in NSE filings, so not counted). Lower ranks higher.0.5522
Interest coverPre-tax profit + interest ÷ interest, last four quarters. Higher ranks higher.-0.4×3
Profit growth consistencyShare of the last 8 quarters with profit above the same quarter a year earlier.4 of 7 quarters38
Free cash flow margin FY26Operating cash flow − capex, as a % of the year’s sales. Higher ranks higher.1.4%42

Valuation: n/a

Camlin Fine Sciences made a loss over the last four quarters, so P/E has no meaning and the valuation score is n/a. A score on book value alone would mislead.

Momentum: 1 (Weak)

How the share price has been trending, against other stocks and NIFTY 50.

ComponentCamlin Fine SciencesPercentile
RS rating12-month return with the latest quarter counted twice, ranked against all NSE stocks we track.1 / 991
vs 200-day averageHow far the price is above (+) or below (−) its 200-day average.-38.7%1
vs 50-day averageHow far the price is above (+) or below (−) its 50-day average.-19.2%2
Place in 52-week range0% = at the 52-week low, 100% = at the 52-week high.0% of the way up0
6-month strength vs NIFTY 50Six-month return minus NIFTY 50’s six-month return.–n/a

18-point checklist

Simple yes/no tests on growth, returns, debt, valuation, trend, holdings and trading. A check is n/a when it doesn’t apply or the data isn’t there; it then doesn’t count either way.

Passes 5 of 15 applicable checks (3 n/a)
#CheckCamlin Fine SciencesResult
1Profit up on a year ago (latest quarter)Rising profit is the main thing that lifts a share’s value over time.−₹28 Cr vs −₹14 CrFail
2Sales up on a year ago (latest quarter)Profit growth lasts longer when it comes with more business, not just cost cuts.+7%Pass
3Profit up year on year in at least 6 of the last 8 quartersSteady growth is easier to rely on than one good quarter.4 of 7 comparableFail
4Return on equity (ROE) of 15% or moreHow much profit the company earns on shareholders’ money.-0.8%Fail
5Return on capital employed (ROCE) of 15% or moreProfit on all the capital in the business, borrowed money included.-1.6%Fail
6Debt below half of equity (D/E under 0.5)Low debt leaves room to get through a bad year.0.55Fail
7Interest cover of 3× or moreOperating profit should cover interest costs comfortably.-0.4×Fail
8Positive free cash flow (latest full year)Cash left after investment is what pays dividends and debt.₹24 Cr (FY26)Pass
9P/E below its sector medianA lower P/E than similar companies means you pay less for each rupee of profit.loss-makingn/a
10P/E below its own 5-year medianCompares today’s price tag with what the market usually paid for this stock.loss-makingn/a
11Price above its 200-day averageThe long-term trend: above the line means the price has been rising over the past ten months.-38.7%Fail
12Price above its 50-day averageThe medium-term trend over about ten weeks.-19.2%Fail
13RS rating of 70 or moreOutperformed at least 70% of NSE stocks over the past year.1Fail
14Promoter holding not reduced last quarterOwners cutting their stake can be a sign they see less value ahead.+0.00 pts to 48.0%Pass
15FII + mutual fund holding up last quarterLarge investors adding shares is a sign of institutional interest.-0.11 pts to 5.9%Fail
16Delivery % (60 days) above the market medianMore shares taken into demat accounts means more investors, fewer day traders.49% vs 48%Pass
17Not under ASM / GSM surveillanceNSE puts stocks with unusual price or volume moves under extra margin and trading rules.not listedPass
18Not in the F&O ban listIn a ban, open interest is near the market-wide limit and only position-reducing trades are allowed.not an F&O stockn/a

Camlin Fine Sciences vs the Chemicals sector

Against the 101 scored stocks in Chemicals. All Chemicals stocks →

Scores vs sector median

ScoreCamlin Fine SciencesSector median
Quality1946
Valuationn/a46
Momentum143

Top 5 in Chemicals by quality score

StockQualityValuationMomentumChecks
Kronox Lab Sciences91467011/15
Pidilite88406115/18
Sharda Cropchem80742813/16
Kiri Industries79n/a549/15
BEPL75725611/15

Questions

What is Camlin Fine Sciences’s quality score?
Camlin Fine Sciences’s quality score is 19 out of 100 (Weak) on 18 Nov 2026, from 6 of 6 components: Return on equity (ROE) -0.8% (percentile 5); Return on capital employed (ROCE) -1.6% (percentile 3); Debt / equity 0.55 (percentile 22); Interest cover -0.4× (percentile 3); Profit growth consistency 4 of 7 quarters (percentile 38); Free cash flow margin FY26 1.4% (percentile 42). It is a rank against 1,356 scored NSE stocks, not an absolute grade.
Is Camlin Fine Sciences expensive?
Camlin Fine Sciences made a loss over the last four quarters, so a P/E cannot be worked out and its valuation score is n/a. Its price-to-book ratio is 1.21, against a sector median of 2.38.
How many checklist points does Camlin Fine Sciences pass?
Camlin Fine Sciences passes 5 of 15 applicable checks on 18 Nov 2026 (3 do not apply or lack data). Passed: sales up on a year ago (latest quarter), positive free cash flow (latest full year), promoter holding not reduced last quarter, delivery % (60 days) above the market median, not under ASM / GSM surveillance. Failed: profit up on a year ago (latest quarter), profit up year on year in at least 6 of the last 8 quarters, return on equity (ROE) of 15% or more, return on capital employed (ROCE) of 15% or more, debt below half of equity (D/E under 0.5), interest cover of 3× or more and more.
How are these scores calculated?
Each score is the average percentile rank of its components among all scored NSE stocks. Quality uses ROE, ROCE, debt/equity, interest cover, how many of the last 8 quarters grew profit year on year, and free cash flow margin (banks, NBFCs and insurers: ROE and profit consistency). Valuation uses P/E against the sector median and against the stock’s own 5-year median, P/B against the sector, and free cash flow yield, with cheaper ranking higher. Momentum uses the RS rating, distance from the 200-day and 50-day averages, place in the 52-week range and 6-month return against NIFTY 50. Scores are relative and change every trading day.

For information and education only; this is not investment advice. ChartMine is not a SEBI-registered investment adviser or research analyst. Scores are relative ranks among NSE stocks and change daily as prices and filings change. Data: NSE daily price files, company results, balance sheets and shareholding filings; a few filings arrive late or contain errors.

See it live on your chart.ChartMine for TradingView.